FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a crystalline hydrated form of hydrochloride LNP023 (form HB), having formula (A), characterized by a powder X-ray diffraction pattern containing at least five peaks at 2-theta angles selected from (4.6±0.2)°, (6.8±0.2)°, (9.2±0.2)°, (10.0±0.2)°, (12.2±0.2)°, (12.6±0.2)°, (15.3±0.2)°, (16.6±0.2)°, (17.2±0.2)°, (19.1±0.2)°, (20.7±0.2)°, (21.3±0.2)°, (22.2±0.2)°, (24.0±0.2)°, (24.6±0.2)° and (28.0±0.2) when measured at a temperature in range from 20 to 30 °C using Cu-Calfa1.2 radiation with wavelength of 0.15419 nm. Method comprises steps of (i) providing LNP023 hydrochloride in solid form; (ii) suspending LNP023 hydrochloride provided in step (i), in a first solvent containing acetone and water, in a weight ratio of acetone to water from 60:40 to 90:10, and heating to a temperature in range of 30 to 56 °C to dissolve a solid to obtain a solution; (iii) cooling the solution obtained in step (ii) and adding a second solvent containing acetone and ethyl acetate in a weight ratio of acetone to ethyl acetate from 0.5:3 to 1:1, with further cooling to a temperature in the range of about 0 to 25 °C to isolate crystals in the mother solution; (iv) separating at least a portion of the crystals obtained in step (iii) from the mother solution; (v) optionally washing the separated crystals obtained in step (iv) with a suitable solvent; and (vi) drying crystals obtained in step (iv) or (v). At step (v), a suitable organic solvent is selected from acetone and ethyl acetate.
EFFECT: obtaining crystalline hydrated form of hydrochloride LNP023 (form HB), having favorable physical and chemical properties.
7 cl, 8 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHENYLEPHRINE RESINATE PARTICLES | 2014 |
|
RU2675788C2 |
COATED PHENYLEPHRINE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS | 2014 |
|
RU2681312C2 |
CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-1-{ 6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL} -1-METHYLUREA AND ITS FRACTIONS | 2010 |
|
RU2572848C2 |
POLYMORPHOUS FORMS OF ICOTINIB MALEATE AND USES THEREOF | 2014 |
|
RU2708079C2 |
POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF | 2014 |
|
RU2710013C2 |
CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR | 2019 |
|
RU2792005C2 |
CRYSTALLINE FORMS OF LTA4H INHIBITOR | 2019 |
|
RU2808992C2 |
CRYSTAL FORMS OF TRIAZOLOPYRIMIDINE COMPOUND | 2017 |
|
RU2754856C2 |
DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
NOVEL POLYMORPHIC FORMS OF ICOTINIB PHOSPHATE AND USES THEREOF | 2014 |
|
RU2712169C2 |
Authors
Dates
2024-05-03—Published
2021-05-17—Filed